USP–NF Compendial Notices

General Announcements are posted on USP's website to provide USP–NF users with general information about the USP–NF, Supplements, Pharmacopeial Forum (PF), or other USP standards-setting activities.

• <7> Labeling (posted 29–Dec–2011)
• <232> <233> <1232>: Metal Impurities Advisory Panel Recommendations to the General Chapters Expert Committee  (posted 02–Jun–2009)
• <467>: Frequently Asked Questions about <467> Residual Solvents
• <1083> Good Distribution Practices—Supply Chain Integrity Posted for Comment, Workshop Scheduled (posted 29–Dec–2011)
• <1121> Stimuli Article and Proposed Revisions (posted 29–Dec–2011)
• Call for Candidates:
  • USP Expert Panel on Extended-Release Dietary Supplement Formulations (posted 20–Jan–2012)
  • USP Expert Panel on Modernization of Identification Tests (posted 27–Jan–2012)
• Pharmacopeial Forum Transitions to a Free, Online Resource in January 2011 (posted 8–Sep–2010)
• Revision to USP Pending Monographs Guideline (posted 23–Nov–2011)
• USP Monograph Modernization Initiative (posted 08–Feb–2011)
• USP Performance Test and the Dissolution Procedure Statement (posted 24–Oct–2006)
• USP Public Statement on Completion of Evaluations of Recall of USP 33–NF 28 (posted 04–Oct–2010)
• USP Revised Admission Criteria and Safety Classification for Dietary Supplements (posted 22–Oct–2009)
• USP Seeks Submission of Proposals for Monograph Modernization (posted 28–May–2010)

USP provides Intent to Revise Announcements to notify users of official text that is under revision.

• <1> Injections and <788> Particulate Matter in Injections (posted 26–Aug–2011)
• <671> Containers—Performance Testing (posted 1–Dec–2007)
• <788> Particulate Matter in Injections and <1> Injections (posted 26–Aug–2011)
• Amoxicillin and Clavulanate Potassium for Oral Suspension (posted 23–Nov–2011)
• Ampicillin (posted 01–Nov–2011)
• Atorvastatin Calcium (posted 25–Feb–2011)
• Benzalkonium Chloride and Benzalkonium Chloride Solution (posted 29–Dec–2011)
• Calcitonin Salmon Monographs (posted 28–Oct–2011)
• Carbidopa (posted 29–Dec–2011)
• Copovidone (posted 09–Aug–2011)
• Ethylcellulose (posted 01–Mar–2011)
• Levelbuterol Hydrochloride (posted 29–Jul–2011)
• Levelbuterol Inhalation Solution (posted 29–Jul–2011)
• Mirtazapine Tablets (posted 29–Jul–2011)
• Modafinil (posted 19–Jun–2009)
• Modafinil Tablets (posted 19–Jun–2009)
• Olanzapine Tablets (posted 27–May–2011)
• Sertraline Tablets (posted 26–Aug–2011)
• Travoprost Ophthalmic Solution (posted 25–Feb–2011)
• Valacyclovir Hydrochloride (posted 30–Jun–2011)
• Vasopressin (posted 31–Mar–2011)

USP–NF Redesigned Monographs

The downloadable Excel file below lists titles of monographs appearing in an official publication (USP–NF or Supplement) in the redesigned format. Monographs are redesigned either through USP’s revision process in the Pharmacopeial Forum (PF) or as part of USP’s ongoing redesign process. The list can be sorted by monograph type, Expert Committee designation, or publication vehicle in which the monograph initially appeared in the redesigned format. This list is updated with the publication of each new USP–NF and Supplement.

• List of monographs appearing in redesigned format as of USP 35–NF 30 First Supplement (posted 27–Jan–2012)

Publications Corrections

• Container Content Reference Corrections in Monographs and General Chapter (posted 27–Jan–2012)
• PF 37(6) Posting (posted 18–Nov–2011)
• USP 34–NF 29 December Errata Posting (posted 30–Dec–2010)

Retired Compendial Notices